IL-17A and IL-17B are primarily involved in the regulation of the tumor immune microenvironment, and they particularly play a special role in the drug resistance and inflammatory response in pancreatic cancer, according to our overview of six different cytokines. This evidence concerns the gene IL17B and familial pancreatic carcinoma.